Apeloa Pharmaceutical Co.,Ltd. (000739) has announced that its wholly owned subsidiary, Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd., has received a Notice of Approval for the Marketing Application of the Chemical Active Pharmaceutical Ingredient for deuterated enzalutamide, issued by the National Medical Products Administration.